Intuitive Surgical (NASDAQ:ISRG) Given New $560.00 Price Target at Argus

Intuitive Surgical (NASDAQ:ISRG) had its price objective decreased by analysts at Argus from $630.00 to $560.00 in a research note issued on Wednesday,MarketScreener reports. The firm presently has a “buy” rating on the medical equipment provider’s stock. Argus’ target price points to a potential upside of 17.28% from the company’s previous close.

Several other equities analysts have also recently weighed in on the stock. Rothschild & Co Redburn lifted their price objective on shares of Intuitive Surgical from $610.00 to $615.00 and gave the stock a “buy” rating in a research report on Thursday, October 23rd. Royal Bank Of Canada lifted their price target on Intuitive Surgical from $625.00 to $650.00 and gave the company an “outperform” rating in a report on Wednesday, December 17th. Evercore ISI reduced their price objective on Intuitive Surgical from $580.00 to $550.00 and set an “in-line” rating for the company in a research note on Friday, January 23rd. Jefferies Financial Group lifted their target price on Intuitive Surgical from $550.00 to $560.00 and gave the company a “hold” rating in a research note on Wednesday, October 22nd. Finally, BTIG Research reiterated a “buy” rating and issued a $616.00 target price on shares of Intuitive Surgical in a report on Friday, January 23rd. Two research analysts have rated the stock with a Strong Buy rating, fifteen have issued a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $617.23.

Intuitive Surgical Stock Performance

Shares of NASDAQ:ISRG traded down $1.01 during midday trading on Wednesday, reaching $477.48. The company had a trading volume of 1,780,802 shares, compared to its average volume of 2,196,473. The company has a fifty day simple moving average of $553.29 and a two-hundred day simple moving average of $510.97. The firm has a market cap of $171.17 billion, a price-to-earnings ratio of 60.45, a price-to-earnings-growth ratio of 3.72 and a beta of 1.65. Intuitive Surgical has a 1-year low of $425.00 and a 1-year high of $609.08.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.27 by $0.26. The firm had revenue of $2.87 billion for the quarter, compared to the consensus estimate of $2.72 billion. Intuitive Surgical had a return on equity of 15.06% and a net margin of 28.38%.The business’s revenue for the quarter was up 18.8% compared to the same quarter last year. During the same quarter in the previous year, the company earned $2.21 EPS. Analysts expect that Intuitive Surgical will post 6.43 EPS for the current year.

Insider Buying and Selling at Intuitive Surgical

In related news, SVP Mark Brosius sold 4,500 shares of Intuitive Surgical stock in a transaction on Friday, December 12th. The shares were sold at an average price of $547.36, for a total value of $2,463,120.00. Following the completion of the sale, the senior vice president owned 907 shares of the company’s stock, valued at approximately $496,455.52. The trade was a 83.23% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Craig H. Barratt sold 750 shares of the stock in a transaction on Wednesday, November 12th. The stock was sold at an average price of $580.00, for a total transaction of $435,000.00. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 73,616 shares of company stock worth $40,929,575 in the last ninety days. Company insiders own 0.70% of the company’s stock.

Institutional Investors Weigh In On Intuitive Surgical

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Tobam boosted its holdings in shares of Intuitive Surgical by 666.7% during the 2nd quarter. Tobam now owns 46 shares of the medical equipment provider’s stock worth $25,000 after buying an additional 40 shares during the period. Holos Integrated Wealth LLC bought a new stake in Intuitive Surgical during the fourth quarter valued at about $25,000. Newbridge Financial Services Group Inc. grew its position in shares of Intuitive Surgical by 300.0% in the fourth quarter. Newbridge Financial Services Group Inc. now owns 44 shares of the medical equipment provider’s stock valued at $25,000 after purchasing an additional 33 shares during the last quarter. Kilter Group LLC bought a new position in shares of Intuitive Surgical in the second quarter worth about $27,000. Finally, Greykasell Wealth Strategies Inc. bought a new position in shares of Intuitive Surgical in the third quarter worth about $27,000. 83.64% of the stock is currently owned by institutional investors and hedge funds.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.